Pulmonx (LUNG) Change in Receivables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Change in Receivables data on file, last reported at -$1.4 million in Q3 2025.

• Change in Receivables for Q3 2025 came in at -$1.4 million, down 492.76% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.3 million (up 70.96% YoY), and the FY2024 annual result was $1.3 million, down 57.86% from the prior year.
• Change in Receivables fell to -$1.4 million in Q3 2025 per LUNG's latest filing, from $1.2 million in the prior quarter.
• Over five years, Change in Receivables peaked at $1.8 million in Q4 2023 and troughed at -$1.4 million in Q3 2025.
• A 5-year average of $503421.1 and a median of $715000.0 in 2023 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 793.41% in 2023, then slumped 492.76% in 2025.
• A 5-year view of Change in Receivables shows it stood at -$387000.0 in 2021, then jumped by 431.78% to $1.3 million in 2022, then surged by 37.23% to $1.8 million in 2023, then declined by 1.19% to $1.7 million in 2024, then slumped by 180.99% to -$1.4 million in 2025.
• Business Quant data shows LUNG's Change in Receivables at -$1.4 million in Q3 2025, $1.2 million in Q2 2025, and $721000.0 in Q1 2025.